Dual-Target CAR-T Therapy: A Breakthrough for Aggressive Brain Tumors
Researchers at McMaster University have developed a new immunotherapy strategy that simultaneously attacks glioblastoma tumors and the immune cells that help them grow. By using Chimeric Antigen Receptor T-cell (CAR-T) therapy to target the GPNMB protein, the study—published July 1 in Nature—demonstrated the ability to eliminate detectable tumors and achieve long-term disease-free survival in pre-clinical … Read more